MISSION

Altrazeal Life Sciences Inc. is a specialty medical technology company committed to developing and commercializing drug delivery systems based on our patented technologies with a mission to:

"Improve the lives of patients the world over by delivering comprehensive care solutions
that optimize outcomes for patients, providers and payers."

tECHNOLOGIES

Wound Care: Altrazeal®

Altrazeal® is a new class of material designed to optimize the wound bed environment to facilitate healing. Presented as a sterile powder, Altrazeal® is unique in application and performance on a moist wound surface. When applied to a moist wound and hydrated with saline, the powder aggregates irreversibly to form a moist wound dressing which conforms to the surface of a wound bed and covers and protects the wound while facilitating the flow of exudate through vapor transpiration.

Transmucosal Drug Delivery: OraDisc

OraDisc is a novel, patented, cost-effective, water-erodible pharmaceutical carrier device, multi-layered device that may be applied to mucosal surfaces, and adheres immediately, delivering actives to treat specific localized diseases/disorders. OraDisc technology can deliver drugs systemically across the mucosal surface or for the release of drugs into the oral cavity. The device is easy to apply and capable of providing tailored erosion rates to deliver therapeutics over different time intervals.

GLOBAL PRESENCE

Our Altrazeal product is available in all states across the United States and in over fifteen countries across Europe, the Middle East, and Latin America.

MISSION

Alrazeal is a specialty medical technology company committed to developing and commercializing drug delivery systems based on our
patented technologies

Our mission is to improve the lives of patients the world over by delivering comprehensive solutions that optimize outcomes for the key stakeholders in our healthcare systems – patients, providers and payers

PRODUCTS

Wound Healing Technology: Altrazeal®

Altrazeal® is a new class of material designed to optimize the wound bed environment and accelerate healing. Produced as a sterile powder, Altrazeal® is unique in application and performance on a moist wound surface. When applied to a moist wound, the powder interacts with wound exudate and hydrates. Hydration with exudate causes the poweder to aggregate irreversibly and form a moist wound dressing which conforms to the surface of a wound bed and seals the wound.

Transmucosal Drug Delivery: OraDisc

A novel, patented, cost-effective, commercially-viable, water-erodible pharmaceutical carrier device, the multi-layered device may be applied to mucosal surfaces, and adheres immediately, delivering actives to treat specific localized diseases/disorders. OraDisc technology can deliver drugs systemically across the mucosal surface or for the release of drugs into the oral cavity. The device causes minimum discomfort, is easy to apply and capable of providing tailored erosion rates to deliver therapeutics over different time intervals.

GLOBAL PRESENCE

Altrazeal Transforming Powder Dressing is available in all states across the United States and in 17 countries across Europe, the Middle East, and Latin America.

Natalia Kirsten

MD

Global Research Advisor

LEADERSHIP:

– Senior Physician, Institute for Services in Health Care Research in Dermatology and Nursing

– Former Resident, Department of Dermatology, Professor Carle Paul Larrey Hospital University of Toulouse, France

EDUCATION:

– University of Hamburg

Natalia Kirsten

mD

Global Research Advisor

LEADERSHIP:

– Senior Physician, Institute for Services in Health Care Research in Dermatology and Nursing

– Former Resident, Department of Dermatology, Professor Carle Paul Larrey Hospital University of Toulouse, France

EDUCATION:

– University of Hamburg

Lawrence A. Lavery

dPM, MPH

Professor, Plastic Surgery, UT Southwestern Medical Center

LEADERSHIP:

– Medical Director, Diabetic Limb Salvage Program, Parkland Hospital

– Member, International Working Group on the Diabetic Foot

– Past chair of the American Diabetes Association Foot Care Counsel and the American Public Health Association’s Foot Section

EDUCATION:

– University of Texas Health Science Center, Dr. William Scholl College of Podiatric Medicine, Indiana University

Lawrence A. Lavery

dPM, MPH

Professor, Plastic Surgery, UT Southwestern Medical Center

LEADERSHIP:

– Medical Director, Diabetic Limb Salvage Program, Parkland Hospital

– Member, International Working Group on the Diabetic Foot

– Past chair of the American Diabetes Association Foot Care Counsel and the American Public Health Association’s Foot Section

EDUCATION:

– University of Texas Health Science Center, Dr. William Scholl College of Podiatric Medicine, Indiana University